Body fat distribution could be a key predictor of heart disease risk in postmenopausal women, according to a July 1 study that found “apple”-shaped women are more prone to CVD than their “pear”-shaped counterparts.

The cardiovascular stents market is expected to reach $13.1 billion by 2025, up from $7.8 billion in 2017, according to projections from Fortune Business Insights.

Infections—most notably urinary tract infections—were linked to a significantly increased risk of acute ischemic stroke in a recent study out of the Icahn School of Medicine at Mount Sinai.

The FDA on June 26 granted Boehringer Ingelheim and Eli Lilly and Company’s drug empagliflozin Fast Track designation for the treatment of chronic heart failure, the companies announced.

Sportswear brand Under Armour filed a patent application this week for a new “smart” shoe that’s able to take a wearer’s blood pressure and help them recover faster from a workout.

Patients prescribed statins for CV risk reduction are more than twice as likely to develop type 2 diabetes compared to non-statin users, a study out of Ohio State University has found.

San Francisco will be the first city in the U.S. to ban the sale and distribution of e-cigarettes, NPR reported Tuesday—a significant move considering the nation’s biggest producer of e-cigs, Juul Labs, is based in the city.

Four universities were awarded research grants by the American Heart Association on June 24, each set to receive more than $3.7 million for a range of studies focused on arrhythmias and sudden cardiac arrest.